Chronic necrotizing pulmonary aspergillosis (CNPA), a form of chronic pulmonary
aspergillosis (CPA), affects immunocompetent or mildly immunocompromised persons with
underlying pulmonary disease. These conditions are associated with high morbidity and
mortality and often require long-term antifungal treatment. The long-term prognosis
for patients with CNPA and the potential complications of CNPA have not been well
documented. The aim of this study was to review published papers that report cases of
CNPA complications and to highlight risk factors for development of CNPA. The
complications in conjunction associated with CNPA are as follows: pseudomembranous
necrotizing tracheobronchial aspergillosis, ankylosing spondylarthritis, pulmonary
silicosis, acute respiratory distress syndrome, pulmonary Mycobacterium avium complex
(MAC) disease, superinfection with Mycobacterium tuberculosis, and and pneumothorax.
The diagnosis of CNPA is still a challenge. Culture and histologic examinations of
bronchoscopically identified tracheobronchial mucus plugs and necrotic material
should be performed in all immunocompromised individuals, even when the radiographic
findings are unchanged. Early detection of intraluminal growth of
Aspergillus and prompt antifungal therapy may facilitate the
management of these patients and prevent development of complications.